Several possible studies
Story checked
4-Week GLP-1 Muscle Growth Workout and Diet Plan (opens in a new tab)
menshealth.com · 2026-10-07
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
4-Week GLP-1 Muscle Growth Workout and Diet Plan
menshealth.com · 2026-10-07
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 6Not checkedGLP-1 drugs can make exercise, especially training meant to build and maintain muscle, more challenging.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 6Not checkedThe new Men’s Health GLP-1 Muscle Growth Plan is a 4-week workout series informed by experts to help readers keep their gains while accounting for the unique needs that come with weight-loss drugs.View evidenceHide evidence
As stated4-week
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 6Not checkedThe goal with weight loss is to maintain muscle, and the best indicator of muscular levels is weight room performance, according to exercise physiologist and strength coach Dr. Pat Davidson.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 6Not checkedBecause GLP-1 drugs reduce appetite and users are likely in a caloric deficit, the article says they may not be able to follow the same high-volume training or high-protein approach associated with strength training.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 6Not checkedThe program recommends decreasing training volume, increasing training intensity, prioritizing progressive overload, and training on fewer days.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 6 of 6Not checkedThe plan uses three training days per week with two to three working sets per movement, with an optional fourth day depending on energy levels, and runs for four weeks.View evidenceHide evidence
As statedthree days per week; optional fourth day; four weeks
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Crossref, Europe PMC · 15 candidate papers
Beyond Skin Laxity: GLP-1 Receptor Agonist-Induced Lean Mass Depletion and Surgical Tissue Quality in Aesthetic Surgery: A Narrative Review.
Aesthetic Surgery Journal. Open Forum · 2026 · PubMed, Crossref
Oral Nutritional Supplements and Body Composition Outcomes Among GLP-1 Receptor Agonist Users: Real-World Evidence.
2026 · Europe PMC
Beyond weight loss: a narrative review of tirzepatide's impact on muscle and lean mass in people with overweight and obesity.
Current Medical Research and Opinion · 2026 · PubMed
12608 Preserving Lean Body Mass During Weight Loss In Elderly Obese Patients With Glp-1 Receptor Agonist Treatment
Journal of the Endocrine Society · 2024 · Crossref
Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. Children 2025, 12, 1427.
2026 · Europe PMC
And 10 more candidates considered.